Risperdal Breast Growth Lawsuits Scheduled For Trial In October, 2015
Written by Stephen Fields on September 1, 2015
Approved for sale by the FDA in 1994, Risperdal is prescribed to treat a variety of mental illnesses, from schizophrenia to bipolar disorder. It’s one of the most popular antipsychotics prescribed to kids. Unfortunately, according to thousands of families, the drug caused their adolescent boys to experience gynecomastia, or male breast enlargement. Today, more than 1,400 Risperdal breast growth lawsuits are pending in a fast-growing mass tort in Philadelphia.
Three trials have already taken place. Two more are scheduled for October with additional cases expected to be heard by jurors in mid-2016. While the verdicts of these early trials are not binding on other claims, they are being watched closely. Their outcomes should provide insight into how other Risperdal claims will be decided by jurors.
Risperdal is manufactured by Janssen Pharmaceuticals, which is wholly owned by Johnson & Johnson. Both companies are under fire for their alleged failure to sufficiently warn the public and medical community about the potential male breast growth risk associated with use of their drug. Critics claim the manufacturers knew about the risk years ago. But instead of warning doctors and their patients, they are accused of choosing to mislead them about the drug’s safety.
If you or your son experienced excessive breast growth after taking Risperdal, you may be able to recover compensation from the manufacturers. Call us toll-free at 1-888-210-9968 today to speak with an attorney about filing a Risperdal lawsuit claim. There is still time to join the mass tort currently under way in Philadelphia.
Pennsylvania Court Readies To Hear More Risperdal Lawsuits
According to a recent article in The Legal Intelligencer, the court overseeing the pending Risperdal mass tort is getting ready to hear several new cases.1 As noted, two lawsuits are scheduled to go to trial in October. In addition, discovery proceedings have begun in 10 more cases, all of which are expected to go to trial in the spring of next year.
These early cases are considered bellwether trials. They give attorneys on both sides an opportunity to test their arguments. They also allow all parties to evaluate how jurors are likely to respond to evidence and testimony in future trials. The goal is to move the litigation forward while identifying whether a Risperdal injury settlement is appropriate, and if so, a suitable amount.
In the dozen cases being prepared for trial in Philadelphia, attorneys are expected to focus on the causal relationship between Risperdal and gynecomastia. The Legal Intelligencer quoted an attorney involved in the bellwether trials as saying “the main issues will be specific causation… My experience is that usually both sides try to get those issues resolved by settlement.”
Risperdal Gynecomastia Lawsuit Results Thus Far
Three lawsuits were scheduled to be heard by jurors earlier this year. In the first case, 20-year-old Austin Pledger, an autistic man living in Alabama, testified that taking Risperdal caused him to develop 46 DD breasts when he was a teen. The jury found that Janssen and J&J were liable for his gynecomastia and awarded him $2.5 million in damages.
The second case was less straightforward. William Cirba, a 19-year-old man living in Pennsylvania, testified that Risperdal caused him to develop female-like breasts. The jury found that Cirba had not adequately proved causation. That being the case, it did not award him damages. But the jury also found that Janssen and J&J had failed to sufficiently warn the public about the link between Risperdal and male breast growth.
In the third case, a lawsuit was filed on behalf of Christopher Walker, who alleged he suffered gynecomastia as a direct result of taking Risperdal. His case was never heard by jurors. Johnson & Johnson negotiated a Risperdal settlement hours before opening arguments were scheduled to be given.
The Risperdal lawsuit settlement offered to Walker wasn’t the first one negotiated by J&J. The drug giant settled several similar cases in 2012.2 The slate of new Risperdal gynecomastia claims currently on the master docket in Philadelphia will provide additional insight into the company’s willingness to settle future cases.
Should You Pursue A Risperdal Gynecomastia Settlement?
Gynecomastia can be devastating to young boys. It can cause extreme embarrassment and set the stage for lasting psychological issues. Worse, in many cases, the condition can only be resolved through surgical intervention.
If you or your son experienced unnatural breast growth after taking Janssen’s antipsychotic, you may be entitled to receive compensation. Call 1-888-210-9968 today for a free, no-obligation case review.
An attorney will review the facts surrounding your case and answer any questions you might have about filing a lawsuit. All claims are accepted on a contingency fee basis. There are never any attorney fees or legal expenses unless we recover compensation for you.
There is limited time to file a claim. Contact our offices at your earliest convenience to find out the filing deadline and receive the legal help you need to pursue a Risperdal male breast growth settlement.